Targeted lung cancer drug shows promise in phase I/II clinical trial
Targeted lung cancer drug shows promise in phase I/II clinical [...]
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer: first results from ARROS-1 phase I clinical trial
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and [...]
Experimental drug to treat liver cancer shows evidence of activity with manageable side effects
Experimental drug to treat liver cancer shows evidence of [...]
Researchers identify specific alterations in the BRAF gene that may affect response to treatment and survival in adult brain cancers
Researchers identify specific alterations in the BRAF gene that may [...]
AKT inhibitor shows signs of effectiveness in a patient trial matching drugs to tumour gene mutations
AKT inhibitor shows signs of effectiveness in a patient trial [...]
Results revealed from phase I clinical trial of the first drug to successfully inhibit the MYC gene, which drives many common cancers
Results revealed from phase I clinical trial of the first [...]
Liquid biopsies can detect which cancer patients may be at higher risk of developing additional blood cancers
Liquid biopsies can detect which cancer patients may be at [...]
